These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19715940)

  • 21. Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection.
    Takemoto R; Nakamuta M; Aoyagi Y; Fujino T; Yasutake K; Koga K; Yoshimoto T; Miyahara T; Fukuizumi K; Wada Y; Takami Y; Saitsu H; Harada N; Nakashima M; Enjoji M
    J Dig Dis; 2009 May; 10(2):145-8. PubMed ID: 19426398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient elastography for patients with chronic hepatitis B and C virus infection: Non-invasive, quantitative assessment of liver fibrosis.
    Ogawa E; Furusyo N; Toyoda K; Takeoka H; Otaguro S; Hamada M; Murata M; Sawayama Y; Hayashi J
    Hepatol Res; 2007 Dec; 37(12):1002-10. PubMed ID: 17608672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
    Sterling RK; Sanyal AJ; Luketic VA; Stravitz RT; King AL; Post AB; Mills AS; Contos MJ; Shiffman ML
    Am J Gastroenterol; 1999 Dec; 94(12):3576-82. PubMed ID: 10606322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of liver fibrosis and cirrhosis by transient elastography among patients with chronic HBV and HCV infection in Georgia.
    Tsertsvadze T; Dolmazashvili E; Abutidze A; Sharvadze L; Karchava M
    Georgian Med News; 2008 Dec; (165):38-42. PubMed ID: 19124915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
    Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
    Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers.
    Sánchez-Conde M; Montes-Ramírez ML; Miralles P; Alvarez JM; Bellón JM; Ramírez M; Arribas JR; Gutiérrez I; López JC; Cosín J; Alvarez E; González J; Berenguer J
    J Viral Hepat; 2010 Apr; 17(4):280-6. PubMed ID: 19732322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
    Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
    J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation.
    Elalfy MS; Esmat G; Matter RM; Abdel Aziz HE; Massoud WA
    Ann Hepatol; 2013; 12(1):54-61. PubMed ID: 23293194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
    Berends MA; Snoek J; de Jong EM; Van Krieken JH; de Knegt RJ; van Oijen MG; van de Kerkhof PC; Drenth JP
    Liver Int; 2007 Jun; 27(5):639-45. PubMed ID: 17498249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
    Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
    HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan).
    Nguyen-Khac E; Capron D
    Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1321-5. PubMed ID: 17099382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study.
    Afdhal NH; Bacon BR; Patel K; Lawitz EJ; Gordon SC; Nelson DR; Challies TL; Nasser I; Garg J; Wei LJ; McHutchison JG
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):772-9.e1-3. PubMed ID: 25528010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutoff values for alcoholic liver fibrosis using magnetic resonance elastography technique.
    Bensamoun SF; Leclerc GE; Debernard L; Cheng X; Robert L; Charleux F; Rhein C; Latrive JP
    Alcohol Clin Exp Res; 2013 May; 37(5):811-7. PubMed ID: 23216352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver stiffness measurement by transient elastography in clinical practice.
    Sporea I; Sirli R; Deleanu A; Popescu A; Cornianu M
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):395-9. PubMed ID: 19104699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of liver biopsy in anti-hepatitis C virus antibody-positive and hepatitis C virus RNA-negative kidney transplant recipients.
    Kim SM; Kim HW; Lee EK; Park SK; Han DJ; Kim SB
    Transplantation; 2013 Jul; 96(1):85-90. PubMed ID: 23632392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-invasive fibrosis assessment in chronic hepatitis C: aspartate-aminotransferase to platelet ratio index (APRI) and transient elastography (FibroScan)].
    Pár A; Pár G
    Orv Hetil; 2010 Nov; 151(47):1951-5. PubMed ID: 21071307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
    Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
    Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.